Related Experiment Video

Updated: May 4, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.1K

Progress in the development of a therapeutic vaccine for breast cancer

Andrew L Coveler1, Nicole E Bates1, Mary L Disis1

  • 1Tumor Vaccine Group, Center for Translational Medicine in Women's Health, University of Washington, Seattle WA, USA.

Breast Cancer (Dove Medical Press)
|December 25, 2013
PubMed

Insights

Cancer vaccines targeting tumor antigens like HER-2/neu, MUC-1, and hTERT show promise for breast cancer. Clinical trials demonstrate their safety and potential for survival benefit, stimulating immune responses.

Area of Science:

  • Oncology
  • Immunology
  • Vaccinology

Background:

  • Human malignancies, including breast cancer, exhibit immunogenicity.
  • Cancer vaccines aim to leverage the immune system for therapeutic benefit.
  • Tumor-associated antigens are key targets for developing effective cancer vaccines.

Purpose of the Study:

  • To review the progress and potential of cancer vaccines in breast cancer treatment.
  • To highlight specific tumor-associated antigens being targeted for vaccination.
  • To assess the safety and efficacy of current breast cancer vaccine strategies.

Main Methods:

  • Review of clinical trials involving breast cancer vaccines.
  • Focus on vaccines targeting human epidermal growth factor receptor 2 (HER-2/neu), mucin 1 (MUC-1), and human telomerase reverse transcriptase (hTERT).
  • Analysis of immune response stimulation and toxicity profiles.

Main Results:

  • Breast cancer vaccines are designed to stimulate cytotoxic and helper T cell responses.
  • Clinical trials have reported progress in targeting antigens like HER-2/neu, MUC-1, and hTERT.
  • Cancer vaccines have demonstrated a favorable safety profile with minimal toxicity.

Conclusions:

  • Breast cancer vaccines are safe and well-tolerated, with minimal adverse effects.
  • Ongoing clinical advances highlight the significant potential clinical benefit of cancer vaccines.
  • Targeting specific tumor antigens offers a promising avenue for improving breast cancer survival rates.
Keywords:
HER-2/neuMUC-1breastcancerhTERTvaccine

More Related Videos

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

4.2K
Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

6.2K

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
144
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K